Antimicrobial Agents and Chemotherapy · 2015 · 83 citations · 18 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial TherapyAntibiotic ResistanceAntimicrobial Susceptibility TestingCarbapenem ResistanceResistance In Gram-negative BacteriaCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenem-hydrolyzing EnzymesCarbapenemase EnzymesClass B Metallo-beta-lactamasesMultidrug-resistant Gram-negative BacteriaOxacillinase CarbapenemasesSpectrum Of Carbapenems
Among 177 carbapenemase-producing Gram-negative bacilli (108 KPC, 32 NDM, 11 IMP, 8 OXA-48, 4 OXA-181, 2 OXA-232, 5 IMI, 4 VIM, and 3 SME producers), aztreonam-avibactam was active against all isolates except two NDM producers with elevated MICs of 8/4 and 16/4 mg/liter; ceftazidime-avibactam was active against all KPC-, IMI-, SME-, and most OXA-48 group-producing isolates (93%) but not metallo-β-lactamase producers. Among older and contemporary antimicrobials, the most active were colistin, tigecycline, and fosfomycin, with overall susceptibilities of 88%, 79%, and 78%, respectively.
18
Laurent Poirel, Thierry Naas, Delphine Nicolas et al. · Antimicrobial Agents and Chemotherapy · 2000 · 558 citations · Full text
David M. Livermore, Shazad Mushtaq, Marina Warner et al. · Antimicrobial Agents and Chemotherapy · 2010 · 255 citations · Full text
Sagar Lahiri, Michele Johnstone, Philip L. Ross et al. · Antimicrobial Agents and Chemotherapy · 2014 · 191 citations · Full text